Icon (ICLR) Other financing activities (2009 - 2026)
Icon's (ICLR) quarterly Other financing activities came in at $1.6 million in Q2 2026, down 6.46% year-over-year from $1.7 million in Q2 2025, and up 49.31% quarter-over-quarter from $1.1 million in Q1 2026.
Analysis
Icon (ICLR) Other financing activities (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Other financing activities for 18 consecutive years, with $1.6 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other financing activities fell 6.46% year-over-year to $1.6 million in Q2 2026; TTM through Jun 2026 was $5.9 million, a 71.79% decrease from a year earlier, with the FY2025 full-year figure at $9.7 million, down 73.13% from the prior year.
- Other financing activities was $1.6 million for Q2 2026 at Icon, up from $1.1 million in the prior quarter.
- Over five years, Other financing activities peaked at $16.3 million in Q3 2023 and troughed at $821000.0 in Q3 2025.
- A 5-year average of $7.5 million and a median of $7.1 million in 2022 frame the typical range for Other financing activities.
- Across the five-year window, Other financing activities surged 149720.0% in 2022 and tumbled 92.35% in 2025, its largest moves.
- Over 5 years, Other financing activities stood at $6.9 million in 2022, then soared by 110.21% to $14.5 million in 2023, then sank by 73.66% to $3.8 million in 2024, then sank by 36.84% to $2.4 million in 2025, then plunged by 32.52% to $1.6 million in 2026.
- The last three Other financing activities figures came in at $1.6 million (Q2 2026), $1.1 million (Q1 2026), and $2.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.62 Mn |
| Mar 31, 2026 | 1.09 Mn |
| Dec 31, 2025 | 2.41 Mn |
| Sep 30, 2025 | 821,000.00 |
| Jun 30, 2025 | 1.74 Mn |
| Mar 31, 2025 | 4.76 Mn |
| Dec 31, 2024 | 3.81 Mn |
| Sep 30, 2024 | 10.73 Mn |
| Jun 30, 2024 | 5.34 Mn |
| Mar 31, 2024 | 16.31 Mn |
| Dec 31, 2023 | 14.46 Mn |
| Sep 30, 2023 | 16.34 Mn |
| Jun 30, 2023 | 7.24 Mn |
| Mar 31, 2023 | 12.94 Mn |
| Dec 31, 2022 | 6.88 Mn |
| Sep 30, 2022 | 13.83 Mn |
| Jun 30, 2022 | 7.65 Mn |
| Mar 31, 2022 | 7.49 Mn |
| Dec 31, 2021 | 14.52 Mn |
| Sep 30, 2021 | 103.89 Mn |